تاثیر تمرینات تناوبی شدید همراه با مصرف عصاره خرفه برسطح سیرتونین1 و مقاومت به انسولین رت های مبتلا به کبد چرب غیر الکلی

1.Iranikhah A, Shapouri J, Heidari A, Aghaali M, Hajian H. Effects of silymarin on nonalcoholic fatty liver disease in children: A crossover clinical trial. Journal of Mazandaran University of Medical Sciences. 2017;26(144):119-26.

2.Carneros D, López-Lluch G, Bustos M. Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD). Nutrients. 2020;12(11):3472.

3.Leoni S, Tovoli F, Napoli L, Serio I, Ferri S, Bolondi L. Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis. World journal of gastroenterology. 2018;24(30):3361.

4.Patel NS, Peterson MR, Lin GY, Feldstein A, Schnabl B, Bettencourt R, et al. Insulin resistance increases MRI-estimated pancreatic fat in nonalcoholic fatty liver disease and normal controls. Gastroenterology research and practice. 2013;2013.

5.Ter Horst KW, Vatner DF, Zhang D, Cline GW, Ackermans MT, Nederveen AJ, et al. Hepatic insulin resistance is not pathway selective in humans with nonalcoholic fatty liver disease. Diabetes care. 2021;44(2):489-98.

6.Guarantee L, Lecture FHE. Sirtuins, aging, and medicine. N Engl J Med. 2011;364:2235-44.

7.Morris BJ. Seven sirtuins for seven deadly diseases ofaging. Free Radical Biology and Medicine. 2013;56:133-71.

8.Satoh A, Stein L, Imai S. The role of mammalian sirtuins in the regulation of metabolism, aging, and longevity. Histone Deacetylases: the Biology and Clinical Implication. 2011:125-62.

9.Guarente L, editor Sirtuins in aging and disease. Cold Spring Harbor symposia on quantitative biology; 2007: Cold Spring Harbor Laboratory Press.

10.Leibiger IB, Berggren P-O. Sirt1: a metabolic master switch that modulates lifespan. Nature medicine. 2006;12(1):34-6.

11.Moynihan KA, Grimm AA, Plueger MM, Bernal-Mizrachi E, Ford E, Cras-Méneur C, et al. Increased dosage of mammalian Sir2 in pancreatic β cells enhances glucose-stimulated insulin secretion in mice. Cell metabolism. 2005;2(2):105-17.

12.Barikani A, Pashaeypoor S. Lifestyle in non-alcoholic fatty liver: A review. Iranian Journal of Nursing Research. 2019;13(6):39-47.

13.Trapp EG, Chisholm DJ, Freund J, Boutcher SH. The effects of high-intensity intermittent exercise training on fat loss and fasting insulin levels of young women. International journal of obesity. 2008;32(4):684-91.

14.Jiménez-Maldonado A, García-Suárez PC, Rentería I, Moncada-Jiménez J, Plaisance EP. Impact of high-intensity interval training and sprint interval training on peripheral markers of glycemic control in metabolic syndrome and type 2 diabetes. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2020;1866(8):165820.

15.Zarei A, Changizi Ashtiyani S, Taheri S. The effects of hydroalcoholic extract of Portulaca Oleracea on the serum concentreation of Hepatic enzymes in Rats. ISMJ. 2014;17(5):889-99.

16.Changizi-Ashtiyani S, Zarei A, Taheri S, Rasekh F, Ramazani M. The effects of Portulaca oleracea alcoholic extract on induced hypercholesteroleomia in rats. Zahedan journal of research in medical sciences. 2013;15(6).

 

17.Asghari S, Asghari-Jafarabadi M, Somi M-H, Ghavami S-M, Rafraf M. Comparison of calorie-restricted diet and resveratrol supplementation on anthropometric indices, metabolic parameters, and serum sirtuin-1 levels in patients with nonalcoholic fatty liver disease: a randomized controlled clinical trial. Journal of the American College of Nutrition. 2018;37(3):223-33.

18.Dehbashi M, Fathie M, Attarzadeh HSR, Mosaferi ZM. The Effect Of Eight Weeks Of Endurance Training And Injection Of Growth Hormone Lipolytic Fragment (Aod9604) On Ck18 And Liver Enzymes Of Nafld-Induced Mice Induced By High-Fat Diet. 2021;15(4):12-19.

19.Barjasteyazdy A, Zarei M. The effect of high intensity interval training (HIIT) with portulaca Oleracea supplementation on serum levels of liver enzyme in rats with non-alcoholic fatty live disease. Journal of Sport and Biomotor Sciences. 2021;26(26):56-65.

20.Silva R, Bueno P, Avó L, Nonaka K, Selistre-Araújo H, Leal A. Effect of physical training on liver expression of activin A and follistatin in a nonalcoholic fatty liver disease model in rats. Brazilian Journal of Medical and Biological Research. 2014;47:746-52.

21.Høydal MA, Wisløff U, Kemi OJ, Ellingsen Ø. Running speed and maximal oxygen uptake in rats and mice: practical implications for exercise training. European Journal of Preventive Cardiology. 2007;14(6):753-60.

22.Hafstad AD, Lund J, Hadler-Olsen E, Höper AC, Larsen TS, Aasum E. High-and moderate-intensity training normalizes ventricular function and mechanoenergetics in mice with diet-induced obesity. Diabetes. 2013;62(7):2287-94.

23.Darvish Damavandi R, Shidfar F, Najafi M, Janani L, Masoodi M, Akbari‐Fakhrabadi M, et al. Effect of Portulaca Oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: A randomized, double‐blind clinical trial. Phytotherapy Research. 2021.

24.Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes care. 2004;27(6):1487-95.

25.Do GM, Oh HY, Kwon EY, Cho Yy, Shin Sk, Park HJ, et al. Long‐term adaptation of global transcription and metabolism in the liver of high‐fat diet‐fed C57BL/6J mice. Molecular nutrition & food research. 2011;55(S2):S173-S85.

26.Brown MS, Goldstein JL. Selective versus total insulin resistance: a pathogenic paradox. Cell metabolism. 2008;7(2):95-6.

27.Chen G, Liang G, Ou J, Goldstein JL, Brown MS. Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proceedings of the National Academy of Sciences. 2004;101(31):11245-50.

28.Cho J, Lee I, Kim D, Koh Y, Kong J, Lee S, et al. Effect of aerobic exercise training on non-alcoholic fatty liver disease induced by a high fat diet in C57BL/6 mice. Journal of exercise nutrition & biochemistry. 2014;18(4):339.

29.Colak Y, Yesil A, Mutlu HH, Caklili OT, Ulasoglu C, Senates E, et al. A potential treatment of non-alcoholic fatty liver disease with SIRT1 activators. J Gastrointestin Liver Dis. 2014;23(3):311-9.

30.Wu T, Liu Y-h, Fu Y-c, Liu X-m, Zhou X-h. Direct evidence of sirtuin downregulation in the liver of non-alcoholic fatty liver disease patients. Annals of Clinical & Laboratory Science. 2014;44(4):410-8.

31.Purushotham A, Schug TT, Xu Q, Surapureddi S, Guo X, Li X. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell metabolism. 2009;9(4):327-38.

32.Kim KE, Kim H, Shin HJ, Yi C-o, Lee DH, Kim HJ, et al. Myeloid-specific SIRT1 deletion aggravates hepatic inflammation and steatosis in high-fat diet-fed mice. The Korean journal of physiology & pharmacology: official journal of the Korean Physiological Society and the Korean Society of Pharmacology. 2015;19(5):451.

33.Deng XQ, Chen LL, Li NX. The expression of SIRT1 in nonalcoholic fatty liver disease induced by high‐fat diet in rats. Liver International. 2007;27(5):708-15.

34.Li Y, Xu S, Giles A, Nakamura K, Lee JW, Hou X, et al. Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver. The FASEB Journal. 2011;25(5):1664-79.

35.Chen S-D, Yang D-I, Lin T-K, Shaw F-Z, Liou C-W, Chuang Y-C. Roles of oxidative stress, apoptosis, PGC-1α and mitochondrial biogenesis in cerebral ischemia. International journal of molecular sciences. 2011;12(10):7199-215.

36.Sun C, Zhang F, Ge X, Yan T, Chen X, Shi X, et al. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell metabolism. 2007;6(4):307-19.

37.Zhou S, Tang X, Chen H-Z. Sirtuins and insulin resistance. Frontiers in Endocrinology. 2018;9:748.

38.Lazo M, Solga SF, Horska A, Bonekamp S, Diehl AM, Brancati FL, et al. Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. Diabetes care. 2010;33(10):2156-63.

39.Saremi A, Sh S, Kavyani A. The Effect of aerobic training on metabolic parameters and 1serumlevel of Sirtuin1 in women with type 2 diabetes. AMUJ. 2016;19(114):88-97.

40.Ghasemi E, Afzalpour ME, Zarban A. The effects of 10 weeks of high-intensity interval training and green tea supplementation on serum levels of sirtuin 1 and catalase in overweight women. 2017.

41.Mohammadi A, Roozbayani M. The long-term effect of moderate-intensity exercise on the expression of the genes irisin and sirtuin-1 in the skeletal muscle of diabetic rats with streptozotocin. Journal of Exercise & Organ Cross Talk. 2022;2(1):1-7.

42.Sarga L, Hart N, Koch L, Britton S, Hajas G, Boldogh I, et al. Aerobic endurance capacity affects spatial memory and SIRT1 is a potent modulator of 8-oxoguanine repair. Neuroscience. 2013;252:326-36.

43.Oliveira NR, Marques SO, Luciano TF, Pauli JR, Moura LP, Caperuto E, et al. Treadmill training increases SIRT-1 and PGC-1α protein levels and AMPK phosphorylation in quadriceps of middle-aged rats in an intensity-dependent manner. Mediators of inflammation. 2014;2014.

44.Casuso RA, Martínez-Amat A, Hita-Contreras F, Camiletti-Moirón D, Aranda P, Martínez-López E. Quercetin supplementation does not enhance cerebellar mitochondrial biogenesis and oxidative status in exercised rats. Nutrition research. 2015;35(7):585-91.

45.Cantó C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature. 2009;458(7241):1056-60.

46.Ajmo JM, Liang X, Rogers CQ, Pennock B, You M. Resveratrol alleviates alcoholic fatty liver in mice. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2008;295(4):G833-G42.

47.Yamazaki Y, Usui I, Kanatani Y, Matsuya Y, Tsuneyama K, Fujisaka S, et al. Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice. American Journal of Physiology-Endocrinology and Metabolism. 2009;297(5):E1179-E86.

48.Walker AK, Yang F, Jiang K, Ji J-Y, Watts JL, Purushotham A, et al. Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. Genes & development. 2010;24(13):1403-17.

49.Utzschneider KM, Kahn SE. The role of insulin resistance in nonalcoholic fatty liver disease. The Journal of Clinical Endocrinology & Metabolism. 2006;91(12):4753-61.

50.Hayoz D, Ziegler T, Brunner HR, Ruiz J. Diabetes mellitus and vascular lesions. Metabolism. 1998;47:16-9.

51.Yang Z, Liu C, Xiang L, Zheng Y. Phenolic alkaloids as a new class of antioxidants in Portulaca oleracea. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 2009;23(7):1032-5.

52.Sicari V, Loizzo MR, Tundis R, Mincione A, Pellicano TM. Portulaca oleracea L.(Purslane) extracts display antioxidant and hypoglycaemic effects. J Appl Bot Food Qual. 2018;91(1):39-46.

53.Alam M, Juraimi AS, Rafii M, Abdul Hamid A, Aslani F, Hasan M, et al. Evaluation of antioxidant compounds, antioxidant activities, and mineral composition of 13 collected purslane (Portulaca oleracea L.) accessions. BioMed research international. 2014;2014.

54.Gheflati A, Adelnia E, Nadjarzadeh A. The clinical effects of purslane (Portulaca oleracea) seeds on metabolic profiles in patients with nonalcoholic fatty liver disease: A randomized controlled clinical trial. Phytotherapy Research. 2019;33(5):1501-9.

55.Andrade JMO, Paraíso AF, de Oliveira MVM, Martins AME, Neto JF, Guimarães ALS, et al. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation. Nutrition. 2014;30(7-8):915-9.

56.Uddin M, Juraimi AS, Hossain MS, Nahar M, Un A, Ali M, et al. Purslane weed (Portulaca oleracea): a prospective plant source of nutrition, omega-3 fatty acid, and antioxidant attributes. The Scientific World Journal. 2014;2014.

57.Jeyapal S, Kona SR, Mullapudi SV, Putcha UK, Gurumurthy P, Ibrahim A. Substitution of linoleic acid with α-linolenic acid or long chain n-3 polyunsaturated fatty acid prevents Western diet induced nonalcoholic steatohepatitis. Scientific reports. 2018;8(1):1-14.

58.Skulas-Ray AC, Kris-Etherton PM, Harris WS, Vanden Heuvel JP, Wagner PR, West SG. Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. The American journal of clinical nutrition. 2011;93(2):243-52.

59.Son SH, Lee SM, Lee MH, Son YK, Kim SE, An WS. Omega-3 Fatty Acids Upregulate SIRT1/3, Activate PGC-1α via Deacetylation, and Induce Nrf1 Production in 5/6 Nephrectomy Rat Model. Marine drugs. 2021;19(4):182.

60.Hussein MA. Purslane extract effects on obesity-induced diabetic rats fed a high-fat diet. Malaysian journal of nutrition. 2010;16(3).